Immune Modulatory DC Vaccine Against Brain Tumor

NCT03914768 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Intrinsic Pontine Glioma or Glioblastoma

Interventions

BIOLOGICAL: Immunomodulatory DC vaccine to target DIPG and GBM

Sponsor

Shenzhen Geno-Immune Medical Institute

Collaborators

[object Object]
[object Object]